Literature DB >> 2900290

The aortic alpha 1-adrenergic receptor in familial amyloidotic polyneuropathy.

T Azuma1, Y Watanabe, T Suzuki, S Sakoda, S Higa, R Mizuno, S Tsujino, S Kishimoto, H Yoshida.   

Abstract

To assess the pathophysiology of the sympathetic nervous system in familial amyloidotic polyneuropathy (FAP), we used 3H-bunazosin to identify and characterize the alpha 1-adrenergic receptor in human aortic membranes. The binding of 3H-bunazosin was rapid, readily reversible, stereospecific, and saturable. The Scatchard analysis described a single class of binding sites with a dissociation constant (KD) of 0.370 +/- 0.035 nM and a maximal binding capacity (Bmax) of 11.8 +/- 1.30 fmol/mg protein in control patients. Competition analysis demonstrated the alpha 1-adrenergic specificity of the 3H-bunazosin binding sites in human aortic membranes. The KD and Bmax of 3H-bunazosin binding in four FAP patients was 0.274 +/- 0.052 nM and 7.79 +/- 0.15 fmol/mg protein, respectively; these values did not differ significantly from those in 14 control patients. An increase in Bmax or affinity of alpha 1-adrenergic receptors may not be the cause for denervation supersensitivity in FAP.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2900290     DOI: 10.1007/bf01244619

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  15 in total

1.  Prazosin, a selective antagonist of post-synaptic alpha-adrenoceptors [proceedings].

Authors:  D Cambridge; M J Davey; R Massingham
Journal:  Br J Pharmacol       Date:  1977-03       Impact factor: 8.739

Review 2.  Inositol phospholipids and cell surface receptor function.

Authors:  R H Michell
Journal:  Biochim Biophys Acta       Date:  1975-03-25

3.  Preferential blockade of presynaptic alpha-adrenoceptors by yohimbine.

Authors:  K Starke; E Borowski; T Endo
Journal:  Eur J Pharmacol       Date:  1975-12       Impact factor: 4.432

Review 4.  Mechanisms of action of transmitters and other substances on smooth muscle.

Authors:  T B Bolton
Journal:  Physiol Rev       Date:  1979-07       Impact factor: 37.312

5.  Characteristics of [3H]E-643-binding to alpha adrenoceptors.

Authors:  F Hata; E Kondo; S Kondo; K Kagawa; H Ishida
Journal:  Jpn J Pharmacol       Date:  1982-02

6.  Hepatic alpha 1-adrenergic receptors show agonist-specific regulation by guanine nucleotides. Loss of nucleotide effect after adrenalectomy.

Authors:  M Goodhardt; N Ferry; P Geynet; J Hanoune
Journal:  J Biol Chem       Date:  1982-10-10       Impact factor: 5.157

7.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

8.  Genetic studies of familial amyloid polyneuropathy in the Arao district of Japan: I. The genealogical survey.

Authors:  S Sakoda; T Suzuki; S Higa; M Ueji; S Kishimoto; A Hayashi; N Yasuda; Y Takaba; A Nakajima
Journal:  Clin Genet       Date:  1983-11       Impact factor: 4.438

9.  Catecholamine metabolism in familial amyloid polyneuropathy.

Authors:  T Suzuki; I Tsuge; S Higa; A Hayashi; Y Yamamura; Y Takaba; A Nakajima
Journal:  Clin Genet       Date:  1979-08       Impact factor: 4.438

10.  Effect of infused L-threo-3,4-dihydroxyphenylserine on adrenergic activity in patients with familial amyloid polyneuropathy.

Authors:  T Suzuki; S Higa; I Tsuge; S Sakoda; A Hayashi; Y Yamamura; Y Takaba; A Nakajima
Journal:  Eur J Clin Pharmacol       Date:  1980-06       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.